Risperdal side effects in boys include breast growth (gynecomastia). Reports include severe enlargement of male breast tissue — up to 38D cup-sizes. The only treatment for Risperdal breast growth is surgery to reduce the size of the breast, remove stretched skin, and liposuction excess fat.
Need a Texas Risperdal Lawyer? Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged. If you or a loved one was injured by Risperdal, you should contact our lawyers immediately. You may be entitled to compensation by filing a lawsuit in Texas.
Risperdal Breast Growth
Risperdal (risperidone) belongs to a class of drugs known as atypical antipsychotics. They treat severe psychiatric conditions by blocking the Dopamine D2 receptors in the brain. Unfortunately, this can cause the pituitary gland to release a hormone called prolactin, which stimulates breast growth and lactation.
Phases of Risperdal breast growth:
- Phase I: Minor breast growth without excess skin
- Phase II: Moderate breast growth without excess skin
- Phase III: Moderate breast growth with excess skin
- Phase IV: Severe breast growth with excess skin
Johnson & Johnson Settles Risperdal Breast Growth Lawsuits
In November 2013, Johnson & Johnson (J&J) agreed to pay $2.2 billion to settle a Risperdal lawsuit brought by the U.S. Department of Justice (DOJ). Prosecutors charged J&J with illegal “off-label” marketing of Risperdal for uses that were not approved by the FDA. These uses included children with ADHD, and moderate behavior disorders. Many of these children developed breast growth.
If you took Risperdal and had breast growth, you are not alone — over 130 Risperdal breast growth lawsuits have been filed against J&J. The first five lawsuits were settled in September and October 2012. All of the plaintiffs took Risperdal as children and developed enlarged breast tissue.
Complications of Breast Growth from Risperdal
For boys and teenagers who develop breasts from Risperdal, it can have devastating effects on their physical and mental health. Most doctors recommend surgery to treat enlarged breasts. The surgery is painful, expensive, and debilitating during recovery time. In addition, young men with breast can suffer psychological trauma if they are teased or self-conscious about their appearance. They may need intensive therapy, counseling, or medications to treat these complications.
Complications of gynecomastia:
- Uneven breasts
- Physical disfigurement
- Psychological trauma
- Mastectomy (removal of the breasts)
- Breast reduction surgery
- Sensory changes
- And more
Studies Link Risperdal and Breast Growth
The first study to link Risperdal and breast growth was published in Psychopharmacology in 1999. Researchers warned that combining Risperdal and Prozac (fluoxetine) led to breast growth.
The evidence continued to grow in 2006, when the Journal of Child and Adolescent Psychopharmacology found that Risperdal could lead to breast growth in young males. Researchers warned:
“Given that the long-term effects of antipsychotic drug-induced hyperprolactinemia are not well documented, especially regarding osteopenia, infertility, growth, and pubertal delay, risperidone should be administered with caution to children and adolescents.”
Evidence of persistent breast growth from Risperdal was published in 2009 by the Journal of Clinical Psychopharmacology. Elevated prolactin levels persisted for up to two years.
Need a Risperdal Lawyer in Texas?
Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.
Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”
The Clark Firm has assembled a team of trial lawyers with more than 100 years experience, participation in over 600 jury trials and $60 million in verdicts and/or settlements. Please use the form below to contact our Texas Risperdal breast growth lawyers for a free lawsuit review.